IPD · ASX

Impedimed Limited (ASX:IPD)

AU$0.051

 0.0 (0.0%)
ASX:Live
20/12/2024 04:10:10 PM
Recent Earnings upgrade HALO Ords HALO Consensus Value GROWTH AUS All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IPD Overview

IPD Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About IPD

Website

Impedimed Limited

Telephone

61.7.3860.3700

Address

Unit 1 50 Parker Court Pinkenba, Queensland (QLD) 4008

Description

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. Its product SOZO, uses bioimpedance spectroscopy technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.

IPD Price Chart

Key Stats

Market Cap

AU$103.20M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.04 - 0.16

Trade Value (12mth)

AU$42,889.00

1 week

-7.27%

1 month

-3.77%

YTD

-64.83%

1 year

-64.83%

All time high

1.74

Key Fundamentals

EPS 3 yr Growth

-43.00%

EBITDA Margin

-210.50%

Operating Cashflow

-$18m

Free Cash Flow Return

-34.30%

ROIC

-38.20%

Interest Coverage

-233.60

Quick Ratio

6.20

Other Data

Shares on Issue (Fully Dilluted)

2023m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.46

IPD Announcements

Latest Announcements

Date Announcements

27 November 24

Change of Director's Interest Notice - Ms Fiona Bones

×

Change of Director's Interest Notice - Ms Fiona Bones

25 November 24

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

×

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

19 November 24

2024 AGM - Chair's Address

×

2024 AGM - Chair's Address

19 November 24

2024 AGM - CEO's Presentation

×

2024 AGM - CEO's Presentation

19 November 24

2024 AGM - Results of Meeting

×

2024 AGM - Results of Meeting

18 November 24

Presentation - Bell Potter Conference

×

Presentation - Bell Potter Conference

04 November 24

Application for quotation of securities - IPD

×

Application for quotation of securities - IPD

24 October 24

Presentation - Wilsons Advisory Drug & Device Conference

×

Presentation - Wilsons Advisory Drug & Device Conference

22 October 24

Quarterly Activities Report and Appendix 4C - Sep-2024 Qtr

×

Quarterly Activities Report and Appendix 4C - Sep-2024 Qtr

22 October 24

Investor Presentation

×

Investor Presentation

21 October 24

Change of Director's Interest Notice - Dr Parmjot Bains

×

Change of Director's Interest Notice - Dr Parmjot Bains

21 October 24

Change of Director's Interest Notice - Mr McGregor Grant

×

Change of Director's Interest Notice - Mr McGregor Grant

18 October 24

Notice of Annual General Meeting and Voting Form

×

Notice of Annual General Meeting and Voting Form

18 October 24

Virtual Meeting Online Guide

×

Virtual Meeting Online Guide

16 October 24

Notification regarding unquoted securities - IPD

×

Notification regarding unquoted securities - IPD

16 October 24

Notification regarding unquoted securities - IPD

×

Notification regarding unquoted securities - IPD

15 October 24

Re-appointment of Non-Executive Director

×

Re-appointment of Non-Executive Director

15 October 24

Notification of Quarterly Results & Investor Conference Call

×

Notification of Quarterly Results & Investor Conference Call

10 October 24

Notification of cessation of securities - IPD

×

Notification of cessation of securities - IPD

10 October 24

Impedimed Limited - Notification of cessation of securities - IPD (IPD-AU)

×

Impedimed Limited - Notification of cessation of securities - IPD (IPD-AU)

10 October 24

Impedimed Limited - Notification of cessation of securities - IPD (IPD-AU)

×

Impedimed Limited - Notification of cessation of securities - IPD (IPD-AU)

08 October 24

NABPC Updated Care Standards to include BIS

×

NABPC Updated Care Standards to include BIS

27 September 24

Date of Annual General Meeting

×

Date of Annual General Meeting

24 September 24

Positive coverage published by two additional payors

×

Positive coverage published by two additional payors

18 September 24

HealthInvest Presentation

×

HealthInvest Presentation

IPD Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 31.4 3.4 14.0 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 24.2 -10.3 -0.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -15.4 -5.7 -12.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.03 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.02 0.02 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 84.3 2.4 -46.5 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,679 1,800 2,022 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,679 1,800 2,022 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 11 11 10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 25.7 7.4 -9.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 8 9 10 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -13 -14 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.4 -2.3 -2.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -126.3 -120.4 -135.4 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 226 220 235 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -18 -20 -22 Lock Lock Lock
     Growth % Lock Lock Lock Lock 13.4 -10.4 -6.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -174.7 -179.6 -210.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 3 2 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -21 -23 -24 Lock Lock Lock
     Growth % Lock Lock Lock Lock 7.8 -7.6 -4.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -200.9 -201.4 -232.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -21 -22 -21 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -2 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -20 -21 -20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 4.0 -3.3 3.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -188.1 -180.9 -191.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -16 -18 -18 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 5 6 3 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -5 -6 -3 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 40 28 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -16 -18 -18 Lock Lock Lock
     Growth % Lock Lock Lock Lock -18.0 -17.3 3.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.5 -1.6 -1.7 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 41 46 25 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 59 69 47 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -41 -44 -23 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 8 8 6 Lock Lock Lock
Equity $m Lock Lock Lock Lock 51 61 41 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 51 62 42 Lock Lock Lock
     Growth % Lock Lock Lock Lock 98.8 21.5 -33.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -33.9 -29.9 -42.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -38.9 -33.7 -48.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -55.0 -40.2 -46.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -51.8 -36.3 -38.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -40.8 -31.9 -34.3 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -659.2 -599.4 -233.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.2 2.2 1.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -79.5 -72.7 -57.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 6.4 8.9 6.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 6.3 8.7 6.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 87.3 88.0 83.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -216.3 -308.7 -382.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.4 2.6 2.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 36.9 28.8 31.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.3 0.2 0.4 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 25.0 11.9 10.6 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -203.0 -194.6 -200.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -36.5 -32.1 -44.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -33.9 -29.9 -42.1 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -38.9 -33.7 -48.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -38.9 -33.7 -48.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 9.9 12.7 11.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 155.1 141.0 134.2 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 165.0 153.7 146.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 29.3 29.3 18.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 135.7 124.4 127.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.46%

Value ($M)

1

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IPD Shortsell

Frequently Asked Questions

The current share price of Impedimed Limited (IPD:ASX) is AU$0.051.
The 52-week high share price for Impedimed Limited (IPD:ASX) is AU$0.16.
The 52-week low share price for Impedimed Limited (IPD:ASX)? is AU$0.04.
Impedimed Limited (IPD:ASX) does not pay a dividend.
Impedimed Limited (IPD:ASX) does not pay a dividend.
Impedimed Limited (IPD:ASX) has a franking level of 0.0%.
Impedimed Limited (IPD:ASX) is classified in the Healthcare.
The current P/E ratio for Impedimed Limited (IPD:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.